{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:29:59Z","timestamp":1784590199506,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.vaccine.2013.08.060","type":"journal-article","created":{"date-parts":[[2013,9,14]],"date-time":"2013-09-14T05:15:27Z","timestamp":1379135727000},"page":"1414-1420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Survey of poliovirus antibodies in Kano, Northern Nigeria"],"prefix":"10.1016","volume":"32","author":[{"given":"Zubairu","family":"Iliyasu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Nwaze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asani O.","family":"Mustapha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goitom","family":"Weldegebriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Gasasira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"Wannemuehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Pallansch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auwalu U.","family":"Gajida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Pate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland W.","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.08.060_bib0005","series-title":"Global eradication of poliomyelitis by the year 2000","author":"World Health Organization","year":"1988"},{"key":"10.1016\/j.vaccine.2013.08.060_bib0010","first-page":"381","article-title":"Progress towards eradicating poliomyelitis: Afghanistan and Pakistan, January 2011\u2013August 2012","volume":"87","author":"World Health Organization","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2013.08.060_bib0015","first-page":"195","article-title":"Progress towards global interruption of wild poliovirus transmission","volume":"87","author":"World Health Organization","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2013.08.060_bib0020","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1126\/science.1130388","article-title":"New strategies for the eradication of polio India","volume":"314","author":"Grassly","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2013.08.060_bib0025","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0140-6736(07)60531-5","article-title":"Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case\u2013control study","volume":"369","author":"Grassly","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.08.060_bib0030","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/infdis\/jiq140","article-title":"Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an under-immunized population","volume":"203","author":"Wassilak","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.060_bib0035","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1056\/NEJMoa0910074","article-title":"Implications of a circulating vaccine-derived poliovirus in Nigeria","volume":"362","author":"Jenkins","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.08.060_bib0040","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMoa0800390","article-title":"Monovalent type 1 oral poliovirus vaccine in newborns","volume":"359","author":"El-Sayed","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.08.060_bib0045","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0140-6736(10)61230-5","article-title":"Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomized, double-blind, controlled trial","volume":"376","author":"Sutter","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.08.060_bib0050","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/S0140-6736(04)16380-0","article-title":"Polio vaccination boycott in Nigeria","volume":"363","author":"Olusanya","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.08.060_bib0055","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/10410236.2011.566830","article-title":"Local resistance to the global eradication of polio: newspaper coverage of the 2003\u20132004 vaccination stoppage in northern Nigeria","volume":"26","author":"Olufowote","year":"2011","journal-title":"Health Commun"},{"key":"10.1016\/j.vaccine.2013.08.060_bib0060","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/tropej\/fmi075","article-title":"Neutralizing antibodies against poliovirus serotypes among children in southwest Nigeria","volume":"52","author":"Adewumi","year":"2006","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.vaccine.2013.08.060_bib0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/tropej\/43.3.187","article-title":"Neutralizing antibodies to poliovirus types 1 and 3 in cord blood of Nigerian children","volume":"43","author":"Odemuyiwa","year":"1997","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.vaccine.2013.08.060_bib0070","first-page":"129","article-title":"Poliovirus antibody in children from a paediatric hospital in Ibadan, Nigeria","volume":"41","author":"Williams","year":"1990","journal-title":"Rev Roum Virol"},{"key":"10.1016\/j.vaccine.2013.08.060_bib0075","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/jmv.23228","article-title":"A survey for neutralizing antibodies to the three types of poliovirus among children in Maiduguri, Nigeria","volume":"84","author":"Baba","year":"2012","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2013.08.060_bib0080","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1016\/j.vaccine.2012.09.023","article-title":"Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria","volume":"30","author":"Giwa","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.060_bib0085","series-title":"Expanded Program on Immunization. Report of a WHO informal consultation on polio neutralization antibody assays, Nashville","year":"1991"},{"key":"10.1016\/j.vaccine.2013.08.060_bib0090","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/infdis\/171.5.1097","article-title":"Factors affecting the immunogenicity of poliovirus vaccine: a prospective evaluation in Brazil and the Gambia","volume":"171","author":"World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.060_bib0095","unstructured":"EpiInfo\/ENA manual at www.cdc.gov\/global health\/gdder."},{"key":"10.1016\/j.vaccine.2013.08.060_bib0100","first-page":"929","article-title":"Use and interpretation of anthropometric indicators of nutritional status","volume":"64","author":"World Health Organization Working Group","year":"1986","journal-title":"Bull WHO"},{"key":"10.1016\/j.vaccine.2013.08.060_bib0105","series-title":"SAS\/STAT user's guide, version 6.4","year":"1989"},{"issue":"June (27)","key":"10.1016\/j.vaccine.2013.08.060_bib0110","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1016\/j.vaccine.2007.04.022","article-title":"Survey of poliovirus antibodies during the final stage of polio eradication in Egypt","volume":"25","author":"El-Sayed","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.060_bib0115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1473-3099(11)70190-6","article-title":"Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6\u20139months in Moradabad, India: a community-based, randomized controlled trial","volume":"12","author":"Est\u00edvariz","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.060_bib0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/096228029300200103","article-title":"The estimation of the basic reproduction number for infectious diseases","volume":"2","author":"Dietz","year":"1993","journal-title":"Stat Methods Med Res"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2013.08.060_bib0125","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1093\/infdis\/175.Supplement_1.S165","article-title":"Outbreaks of paralytic poliomyelitis, 1976\u20131995","volume":"175","author":"Patrtiarca","year":"1997","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13011729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13011729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T03:23:10Z","timestamp":1539400990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13011729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0264410X13011729"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.060","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survey of poliovirus antibodies in Kano, Northern Nigeria","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}